Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4979

Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response

Analysis of lapatinib-resistant ErbB2-positive cells treated with 0.1 or 1 uM lapatinib. Lapatinib is an EGFR/ErbB2 inhibitor used to treat ErbB2‐positive advanced or metastatic breast cancer. Results provide insight into the mechanisms underlying the development of resistance to lapatinib.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 2 cell type, 3 dose sets

Platform:: GPL6947
Series:: GSE38376
18 Samples

DataSet

Accession:: GDS4979

ID:: 4979

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response
Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response
Accession: GDS4979

GEO DataSets
Related DataSets for GEO Profiles (Select 108834185) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets